How is Mölnlycke Improving Patient Care and Planet Health?
In 2025, Mölnlycke Health Care continued its 176-year legacy of clinical innovation by delivering sustainable solutions that improve lives for patients and caregivers in more than 100 countries, emphasised in its 2025 annual report.
Despite significant financial and operational pressures facing global healthcare systems, the company achieved a 4% organic sales growth and reinforced its position as a world-leading MedTech specialist.
By integrating customer-centricity with ambitious sustainability and digitalisation targets, Mölnlycke is actively working to revolutionise care for both people and the planet.
Strategic expansion and localised care
Mölnlycke made major strides in its localisation strategy during 2025 to enhance supply chain resilience and meet rising regional demands.
The company initiated a âŹ115m (US$134.5m) expansion of its wound care manufacturing capacity in Brunswick, Maine, to serve the growing US market.
Additionally, it established its first wound care manufacturing site in Changshu, China and launched ProcedurePak tray assembly operations in Saudi Arabia and Thailand, ensuring faster delivery and better support for local healthcare providers.
These expansions are designed to mitigate risks from geopolitical volatility and trade restrictions while bringing life-saving products closer to the patients who rely on them most
Innovation in clinical efficiency
Addressing critical inefficiencies in healthcare settings remained a top priority for the company's business areas.
âTodayâs world is shifting faster and more unpredictably than many of us have experienced before,â says Zlatko Rihter, CEO, in the companyâs 2025 annual report.
âThis makes focused execution more critical than ever.
âWe succeed by staying close to our customers, making selective and disciplined choices and acting with immediate clarity and long-term commitment.â
The Operating Room (OR) Solutions segment launched the "2025 Non-Value Report," which surveyed more than 200 nurses to uncover how procedural bottlenecks compromise patient safety and staff wellbeing.
In Wound Care, the launch of Mepilex Up in EMEA and Canada provided advanced leg ulcer management designed to minimise leakage, while the "Wound Care for All" program introduced the Skin Tone I.D. tool to support inclusive skin assessments and reduce diagnostic bias.
Furthermore, the Gloves segment introduced a tenfold stricter endotoxin standard for its Biogel Tech gloves, significantly enhancing safety for aseptic operations in high-risk pharmaceutical environments.
A commitment to sustainability and net zero
Mölnlyckeâs sustainability roadmap, WeCare, reached several key milestones in 2025, including the validation of its long-term net zero greenhouse gas emission targets by the Science Based Targets initiative (SBTi).
The company has already achieved a 52% reduction in Scope 1 and 2 emissions compared to its 2021 baseline and maintains 100% renewable electricity use across all manufacturing sites and its new LEED Platinum-certified global headquarters in Gothenburg.
Furthering its circular economy goals, the company successfully concluded a closed-loop recycling pilot that chemically recycled post-consumer waste from operating rooms to produce new surgical drapes.
The company also made the pioneering move of donating a patient risk assessment patent to an open-access platform to accelerate sustainable healthcare innovation across the entire industry.
Digital transformation and future resilience
To support data-driven decision-making and operational efficiency, Mölnlycke implemented a new cloud-based ERP platform, SAP S/4 HANA, capable of handling more than 500,000 daily transactions.
The company is also prioritising AI literacy, with approximately 1,800 employees participating in "AI Power Hours" to explore responsible clinical applications of artificial intelligence.
These digital initiatives, combined with a focus on high-quality decolonisation solutions in the Antiseptics business area, position Mölnlycke to lead the industry in navigating an increasingly complex healthcare landscape.
By modernising its IT foundation and exploring new digital ventures, the company aims to streamline workflows for healthcare professionals, ultimately allowing them to spend more time on direct patient care
